Abstracts tagged "Osteoarthritis"

Abstract Number: 1129 • 2012 ACR/ARHP Annual Meeting
Prevalence of Symptomatic Basilar Thumb Joint Osteoarthritis in the General Population
Jennifer Moriatis Wolf¹, Aleksandra Turkiewicz², Isam Atroshi³ and Martin Englund², ¹Orthopaedic Surgery, University of Connecticut Health Center, Farmington, CT, ²Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden, ³Department of Orthopedics Hässleholm-Kristianstad, Lund University, Hässleholm, Sweden
Prevalence of symptomatic basilar thumb joint osteoarthritis in the general population Background/Purpose: While the radiographic prevalence of basilar thumb osteoarthritis (OA) is well described, little…
Abstract Number: 799 • 2012 ACR/ARHP Annual Meeting
Does Unpredictable Intermittent Knee Pain Limit Functional Ability and Walking Frequency in Knee OA?
Daniel K. White¹, Gillian A. Hawker², David T. Felson³, K. Douglas Gross⁴, Jingbo Niu⁵, Michael C. Nevitt⁶, C.E. Lewis⁷, James Torner⁸ and Tuhina Neogi⁹, ¹Department of Physical Therapy, University of Delaware, Newark, DE, ²Women's College Research Institute, University of Toronto, Toronto, ON, Canada, ³Boston University, Boston, MA, ⁴Physical Therapy, MGH Institute of Health Professions, Boston, MA, ⁵Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ⁶Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, ⁷University of Alabama, Birmingham City, AL, ⁸Epidemiology, University of Iowa, Iowa City, Iowa City, IA, ⁹Boston University School of Medicine, Boston, MA
Background/Purpose: People with knee osteoarthritis (OA) reported that unpredictable pain restricts their ability to engage in physical activities in a qualitative study. Since walking is…
Abstract Number: 18 • 2012 ACR/ARHP Annual Meeting
Identification of 14-3-3å As a New Subchondral Bone Mediator Involved in Cartilage Degradation During Osteoarthritis
Sabrina Priam Jr.¹, Carole Bougault¹, Xavier Houard², Marjolaine Gosset³, Colette Salvat⁴, Francis Berenbaum⁵ and Claire Jacques¹, ¹Ur-4, Pierre et Marie Curie University Paris VI, Paris, France, ²Sorbonne Universités, UPMC Univ Paris 06, UMRS 938 and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France, ³EA 2496, Paris Descartes University, Montrouge, France, ⁴UR4, University Pierre and Marie Curie, Paris, France, ⁵Rheumatology, AP-HP, St Antoine Hospital, Paris, France
Background/Purpose: OA is a complex disease not limited to cartilage degeneration. Indeed, several experiments suggest that subchondral bone remodeling could initiate and/or contribute to cartilage…
Abstract Number: 1131 • 2012 ACR/ARHP Annual Meeting
Intraarticular Infliximab for Knee Osteoarthritis: High Baseline Levels of Synovial Cellularity and High MRI Cartilage Injury At the Lateral Tibial Plateau Predict Improvement in Total WOMAC Score
Jeremy R. Schue¹, Ossama Tawfik², Rebecca Bolce³, Donald D. Smith¹, Gary Hinson⁴, Jo A. Wick⁵ and Herbert B. Lindsley⁶, ¹Internal Medicine, Kansas University Med Ctr, Kansas City, KS, ²Pathology, Kansas University Med Ctr, Kansas City, KS, ³Crescendo Bioscience Inc., South San Francisco, CA, ⁴Radiology, Kansas University Med Ctr, Kansas City, KS, ⁵Biostatistics, Kansas University Med Ctr, Kansas City, KS, ⁶Medicine, Kansas University Med Ctr, Kansas City, KS
Background/Purpose: Synovial tissue from patients with OA often demonstrates inflammation. We hypothesized that a single intraarticular (IA) injection of an anti-TNF drug would decrease inflammatory…
Abstract Number: 733 • 2012 ACR/ARHP Annual Meeting
Intra-Articular Injection of Adipose-Derived Stem Cells Inhibits Activation of the Synovium and Protects Against Cartilage Damage and Enthesophyte Formation in Murine Experimental Osteoarthritis
Peter L.E.M. van Lent¹, Menno C. ter Huurne², Arjen B. Blom³, Rik Schelbergen³, Louis Casteilla⁴, Thomas Vogl⁵, Johannes Roth⁵, Roxane Blattes⁴, Christian Jorgensen⁶ and Wim B. van den Berg⁷, ¹Rheumatology Research & Advanced Therpeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ²Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ³Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ⁴STROMALab UPS/CNRS UMR5273, INSERM U1031, Toulouse, France, ⁵Institute of Immunology, University of Muenster, Munster, Germany, ⁶Department of therapy & Immuno-Rhumatology, Hospital Lapeyronie, Montpellier, France, ⁷Experimental Rheumatology (272), Radboud university medical center, Nijmegen, Netherlands
Background/Purpose: OA lesions are treated with mesenchymal stem cells aiming to enhance tissue repair by transformation to eg. chondrocytes. Recently it has been shown that…
Abstract Number: 1132 • 2012 ACR/ARHP Annual Meeting
Prevalence of Knee Pain in Ultramarathon Runners
Victoria M. Kelly¹, Martin Hoffman², Bharathi Lingala³, Mihoko Bennett⁴ and Eswar Krishnan⁵, ¹Department of Medicine, Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA, ²Physical Medicine and Rehabilitation, Department of Veteran's Affairs, Northern California Health Care System and University of California Davis Medical Center, Sacramento, CA, ³Stanford University, Palo Alto, CA, ⁴Pediatrics, Stanford University, Palo Alto, CA, ⁵Division of Rheumatology, Stanford University, Palo Alto, CA
Prevalence of Knee Pain in Ultramarathon Runners Background/Purpose: Approximately one in four Americans suffer from frequent knee pain. While some studies have linked long-distance running…
Abstract Number: 744 • 2012 ACR/ARHP Annual Meeting
Racial Differences in Reported Knee Pain Severity Persist Even After Adjustment for Knee Examination and Radiographic Findings: Data From the Osteoarthritis Initiative
Paige Luneburg¹, Laura Yerges-Armstrong², Braxton D. Mitchell² and Marc C. Hochberg¹, ¹Department of Medicine, University of Maryland, Baltimore, MD, ²Departments of Medicine and Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, MD
Background/Purpose: African Americans have a higher prevalence of both radiographic and symptomatic radiographic knee osteoarthritis (OA) than Caucasians. In addition, African Americans with knee OA…
Abstract Number: 1134 • 2012 ACR/ARHP Annual Meeting
What Are the Levels of Physical Activities and Their Associations with Quality of Life in Patients with Symptomatic Hip and/or Knee Osteoarthritis?
Irawati Lemonnier¹, Anne Vuillemin² and Anne-Christine Rat³, ¹Lorraine Université Paris Descartes University, EA 4360 Apemac, Nancy, France, Nancy, France, ²Universite de Lorraine, Paris Descartes University, EA 4360 Apemac, Nancy, France, Nancy, France, ³CHU Nancy, Clinical Epidemiology and Evaluation, Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France
Background/Purpose: Physical activities (PA) practice is recommended by numerous public health organizations. According to international recommendations, patients with hip and knee osteoarthritis (OA) should be…
Abstract Number: 745 • 2012 ACR/ARHP Annual Meeting
Soft Drink Intake and Progression of Radiographic Knee Osteoarthritis: Data From the Osteoarthritis Initiative
Bing Lu¹, Jeffrey Driban², Tim McAlindon³ and Charles Eaton⁴, ¹Rheumatology, Brigham and Women's Hospital, Boston, MA, ²Tufts Medical Center, MA, ³Tufts Medical Center, Boston, MA, ⁴Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Providence, RI
Soft Drink Intake and Progression of Radiographic Knee Osteoarthritis: Data from the Osteoarthritis InitiativeBackground/Purpose : Soft drink consumption has been associated with weight gain and…
Abstract Number: 2630 • 2012 ACR/ARHP Annual Meeting
Rheumatoid Arthritis and Osteoarthritis in the Population: How Different Is the Impact?
Christina H. Chan¹, Mayilee Canizares² and E.M. Badley³, ¹Division of Healthcare Outcomes and Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ²Division of Healthcare Outcomes and Research, Toronto Western Research Institute, Toronto, ON, Canada, ³Division of Health Care and Outcomes Research, Toronto Western Research Institute; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
Background/Purpose: It is a common perception that rheumatoid arthritis (RA) is a more severe and debilitating disease than osteoarthritis (OA); however, there have been many…
Abstract Number: 1099 • 2012 ACR/ARHP Annual Meeting
Whole Blood Lead Is Associated with Symptoms, but Not Radiographic Osteoarthritis, in Multiple Joint Sites: The Johnston County Osteoarthritis Project
Amanda E. Nelson¹, Xiaoyan A. Shi², Todd A. Schwartz³, Jordan B. Renner⁴, Kathleen L. Caldwell⁵, Charles G. Helmick⁶ and Joanne M. Jordan⁷, ¹University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC, ²SAS Institute, Inc, Cary, NC, ³University of North Carolina Gillings School of Global Public Health, Dept of Biostatistics, Chapel Hill, NC, ⁴University of North Carolina School of Medicine, Dept of Radiology, Chapel Hill, NC, ⁵Centers for Disease Control and Prevention, Atlanta, GA, ⁶National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, ⁷Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC
Background/Purpose: We have previously identified associations between whole blood lead (Pb) and knee osteoarthritis (OA) and with biomarkers of joint metabolism. We hypothesized that Pb…
Abstract Number: 272 • 2012 ACR/ARHP Annual Meeting
Interim Safety Analysis of a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy Study of Apremilast (CC10004) in Subjects with Erosive Hand Osteoarthritis
Juergen Rech¹, Wolfgang Ochs², Wolfgang Spieler³, Herbert Kellner⁴, Ulf Müller-Ladner⁵, Mathias Grunke⁶, Matthias Schneider⁷ and Georg Schett⁸, ¹Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, ²Rheumatologist in private practice, Bayreuth, Germany, ³Rheumatology Specialty Practice, Zerbst, Germany, ⁴Centre for Inflammatory Joint Diseases, Munich, Germany, ⁵Abt. f. Rheumatologie u. klinische Immunologie, Osteologie, Physikalische Therapie, Kerckhoff-Klinik GmbH, Bad Nauheim, Germany, ⁶Division of Rheumatology, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany, ⁷Department of Endocrinology, Diabetes and Rheumatology, Heinrich-Heine-University, Duesseldorf, Germany, ⁸Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
Background/Purpose: Apremilast is a small molecule,specific phospodiesterase4 inhibitor under investigation for a number of inflammatory conditions, including psoriasis and psoriatic arthritis. We report results of…
Abstract Number: 2517 • 2012 ACR/ARHP Annual Meeting
Inhibition of Notch Signaling Increases the Severity of Experimental Osteoarthritis
Neng-Yu Lin¹, Alfiya Distler¹, Christian Beyer², Clara Dees³, Jingang Huang³, Francesco Dell'Accio⁴, Oliver Distler⁵, Georg A. Schett⁶ and Joerg HW Distler¹, ¹Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ²Department of Internal Medicine 3, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ³Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ⁴William Harvey Research Institute, Barts and the London Queen Mary's School of Medicine and Dentistry, Centre for Experimental Medicine and Rheumatology, London, United Kingdom, ⁵Department of Rheumatology and Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, ⁶Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
Background/Purpose: Notch signaling is triggered by binding of ligands such as Jagged-1 (Jag-1) to Notch receptors, which results in cleavage of Notch receptors by the…
Abstract Number: 1103 • 2012 ACR/ARHP Annual Meeting
Cumulative Occupational Physical Load As Risk Factor for Knee Osteoarthritis
Allison M. Ezzat¹, Jolanda Cibere², Mieke Koehoorn³, Eric C. Sayre⁴ and Linda C. Li⁵, ¹School of Rehabilitation Science, University of British Columbia, Vancouver, BC, Canada, ²Division of Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ³University of British Columbia, Vancouver, BC, Canada, ⁴Arthritis Research Centre of Canada, Vancouver, BC, Canada, ⁵Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Knee osteoarthritis (OA) results from the interaction of multiple risk factors, one of which may be physically demanding occupations. The purpose of this study…
Abstract Number: 248 • 2012 ACR/ARHP Annual Meeting
Synovial Fluid Leptin Level Is Associated with Residual Pain and Functional Disability One Year After Total Joint Arthroplasty
Anne Lübbeke¹, Gabor J. Puskas¹, Axel Finckh², Domizio Suva¹, Sylvette Bas³, Cem Gabay³, Daniel Fritschy¹ and Pierre Hoffmeyer¹, ¹Orthopaedic Surgery, Geneva University Hospitals, Geneva, Switzerland, ²Rheumatology, Geneva University Hospitals, Geneva 14, Switzerland, ³Rheumatology, Geneva University Hospitals, Geneva, Switzerland
Background/Purpose: A sizeable number of patients continue to suffer from pain, functional disability and reduced quality of life after total joint arthroplasty (TJA). The etiology…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].